Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | DBH | P09172 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | HTR1B | P28222 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.36 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 2/20 | 0.35 |
| ▸ | MAOB | P27338 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17559555 | 0.94 | KDM4E (0.44) | KDM4EDBHGAARECQLRAB9A | |
| SCHEMBL11800787 | 0.81 | ABCC4 (0.35) | KDM4EDBHGAARECQLRAB9A | |
| SCHEMBL11800462 | 0.80 | NPC1 (0.63) | KDM4ERECQLRAB9ANPC1MAPT | |
| SCHEMBL11751146 | 0.78 | ALDH1A1 (0.53) | KDM4EGAARAB9ANPC1MAPT | |
| SCHEMBL10852486 | 0.78 | MAOA (0.52) | RAB9ANPC1ABCC4PTGS1MAOA | |
| SCHEMBL11191099 | 0.77 | TAS1R3 (0.59) | KDM4EDBHGAARECQLRAB9A | |
| SCHEMBL10848578 | 0.76 | MAOA (0.50) | RAB9ANPC1ABCC4PTGS1MAOA | |
| SCHEMBL3008104 | 0.76 | GAA (0.49) | KDM4EDBHGAARECQLRAB9A | |
| SCHEMBL17559571 | 0.76 | GAA (0.49) | KDM4EDBHGAARECQLRAB9A | |
| SCHEMBL11797647 | 0.75 | HPGD (0.41) | KDM4EALDH1A1TAS1R3TAS1R1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3189083-B2 | POLYCYCLIC PHOTOINITIATORS | IGM GROUP B V (NL) | 2023-07-05 | — | — | EP | disclosed |
| EP-3189083-B2 | POLYCYCLIC PHOTOINITIATORS | IGM GROUP B V (NL) | 2023-07-05 | — | — | EP | disclosed |
| EP-3189083-B1 | POLYCYCLIC PHOTOINITIATORS | IGM GROUP B V (NL) | 2020-04-08 | — | — | EP | disclosed |
| CN-107075000-B | Polycyclic photoinitiators | IGM集团公司 | 2020-01-31 | — | — | CN | disclosed |
| US-10113075-B2 | Polycyclic photoinitiators | IGM MALTA LIMITED (MT) | 2018-10-30 | — | — | US | disclosed |
| US-20170240755-A1 | POLYCYCLIC PHOTOINITIATORS | IGM GROUP B.V. (NL) | 2017-08-24 | — | — | US | disclosed |
| US-20170240755-A1 | POLYCYCLIC PHOTOINITIATORS | IGM GROUP B.V. (NL) | 2017-08-24 | — | — | US | disclosed |
| US-20170240755-A1 | POLYCYCLIC PHOTOINITIATORS | IGM GROUP B.V. (NL) | 2017-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170240755-A1 | POLYCYCLIC PHOTOINITIATORS | C1R, C9, C5 | KDM4E 2961/4885DBH 3268/4885GAA 4856/4885 |
| US-10113075-B2 | Polycyclic photoinitiators | C1R, C9, C5 | KDM4E 2923/4885DBH 3267/4885GAA 4857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.